Avanos Medical, Inc. · NYSE:AVNS
T. Rowe Price Investment Management, Inc. reported a 8.20% stake in Avanos Medical, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
T. Rowe Price Investment Management, Inc. reported a 8.20% stake in Avanos Medical, Inc., 3,757,576 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 3,757,576
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 8.20% | 3,757,576 |
Source
Related
- Avanos Medical, Inc.
- T. Rowe Price Investment Management, Inc.
- Avanos Medical, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Feb 14, 2025
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Delgado Sigfrido · Jul 28, 2026
- Form 4 · Galovan Scott Michael · Jul 28, 2026
- Form 4 · Pacitti David · Jul 28, 2026
- Form 4 · Shimer Julie Ann · Jul 28, 2026